Bank Syariah Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Syariah Indonesia Tbk trades at Rp1,785 (market cap 81.06T, 7.64M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Bank Syariah Indonesia Tbk is far larger — about 492.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Syariah Indonesia Tbk is more actively traded (7.64M versus 43.9K). Which is the better fit depends on your goals.
| BRIS | OBAT | |
|---|---|---|
Market Cap | 81.06T | 164.65B |
Volume | 7.64M | 43.9K |
Lot | 76.38K | 439 |
Turnover | 13.59B | 10.6M |
Average Price | 1,779.36 | 241.43 |
Value | 13.59B | 10.6M |
Indicative Equilibrium Price | 1,780 | 238 |
Indicative Equilibrium Volume | 130 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank BRISyariah Tbk (the Bank) is located in Jakarta, Indonesia, and initially established under the name of PT Bank Jasa Arta (BJA) based on the Deed of Establishment No. 4 dated April 3, 1969 of Liem Toeng Kie, S.H., Notary in Jakarta.
Read more on BRIS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →